Harvard University

University / College


Location: Cambridge, MA, United States (USA) (US) US

ISNI: 000000041936754X

ROR: https://ror.org/03vek6s52

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Predicting plastron thermodynamic stability for underwater superhydrophobicity (2024) Tesler A, Nurmi HA, Kolle S, Prado L, Karunakaran B, Mazare AV, Erceg I, et al. Journal article Bi-allelic variants in CELSR3 are implicated in central nervous system and urinary tract anomalies (2024) Stegmann JD, Kalanithy JC, Dworschak GC, Ishorst N, Mingardo E, Lopes FM, Ho YM, et al. Journal article METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII (2024) Kocak B, Akinci D’Antonoli T, Mercaldo N, Alberich-Bayarri A, Baessler B, Ambrosini I, Andreychenko AE, et al. Journal article Integrating genetic regulation and single-cell expression with GWAS prioritizes causal genes and cell types for glaucoma (2024) Hamel AR, Yan W, Rouhana JM, Monovarfeshani A, Jiang X, Mehta PA, Advani J, et al. Journal article Tailoring the Use of Central Pancreatectomy Through Prediction Models for Major Morbidity and Postoperative Diabetes: International Retrospective Multicenter Study (2024) Van Bodegraven EA, Lof S, Jones L, Aussilhou B, Yong G, Jishu W, Klotz R, et al. Journal article Common variants increase risk for congenital diaphragmatic hernia within the context of de novo variants (2024) Qiao L, Welch CL, Hernan R, Wynn J, Krishnan US, Zalieckas JM, Buchmiller T, et al. Journal article MARK2 variants cause autism spectrum disorder via the downregulation of WNT/β-catenin signaling pathway (2024) Gong M, Li J, Qin Z, Machado Bressan Wilke MV, Liu Y, Li Q, Liu H, et al. Journal article Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)] (2024) de Azambuja E, Piccart-Gebhart M, Fielding S, Townend J, Hillman DW, Colleoni M, Roylance R, et al. Journal article The Infiltrative Margins in Glioblastoma: Important Is What Has Been Left behind (2024) Karschnia P, Tonn JC, Cahill DP Journal article ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment (2024) Adamina M, Minozzi S, Warusavitarne J, Buskens CJ, Chaparro M, Verstockt B, Kopylov U, et al. Journal article